跳至主要内容
临床试验/NCT00310778
NCT00310778已完成1 期

Effects of Sodium Intake on Pharmacokinetic/Pharmacodynamic Relationship of a Single Dose of a Renin Angiotensin System-Blocker, or a Beta-Blocker in Normotensive Sodium-Depleted or Replated Volunteers in a Cross-Over Study

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2006年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
64
试验地点
1
主要终点
Area under the curve (AUC) up to the 48 hour time point of plasma drug concentrations between a replated-sodium diet and sodium depletion

研究概览

简要总结

The impact of sodium intake on plasma drug concentrations has previously been reported in the literature for verapamil and quinidine but, to the investigators' knowledge, never with renin-angiotensin system blockers such as AT1R antagonists and angiotensin converting enzyme inhibitors.

详细描述

The impact of sodium intake on plasma drug concentrations concentrations obtained after a single oral dose of RAS blocking drugs (ramipril 10 mg, valsartan 160 mg, candesartan 8 mg) or a blocker as control (ATENOLOL 50 mg) will be compared in healthy normotensive men randomly assigned to a 6-day replated-sodium diet or a sodium depletion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 64 (16 per treatment goup) non-smoking healthy male volunteers
  • Aged between 18 and 35 years after a complete clinical examination
  • Safety laboratory measurements
  • Having given written informed consent.

排除标准

  • hypertension
  • known disease
  • diabetes mellitus
  • known hypersensitivity
  • contraindication to ACE inhibitors
  • history of cardiac or pulmonary disease or asthma conditions which do not permit medical follow-up and compliance with the study protocol.

研究组 & 干预措施

1

Experimental

treatment

干预措施: valsartan 160 mg (Drug)

1

Experimental

treatment

干预措施: high sodium diet (Drug)

1

Experimental

treatment

干预措施: low sodium diet (Drug)

1

Experimental

treatment

干预措施: ramipril 10 mg (Drug)

1

Experimental

treatment

干预措施: candesartan 8 mg (Drug)

1

Experimental

treatment

干预措施: atenolol 50 mg (Drug)

结局指标

主要结局

Area under the curve (AUC) up to the 48 hour time point of plasma drug concentrations between a replated-sodium diet and sodium depletion

时间窗: 48 hours

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Effects of Sodium Intake on (PK/PD) Relationship of... | 临床试验